By Dr. John L. Ferrell III, M.D.(*)
⚡ Quick Answer: PRP or Cortisone for Hip Arthritis?
- Cortisone reduces inflammation and pain quickly, often within days, but it does not repair joint tissue, and hip-specific research has raised real concern that repeated use can accelerate cartilage breakdown and, in some cases, more serious joint damage.
- PRP works more slowly, typically over several weeks, but aims at a different goal: supporting the joint’s own repair processes rather than temporarily suppressing symptoms.
- The hip joint’s deeper location makes precise injection placement more technically demanding than the knee, which is why ultrasound guidance matters even more here.
- Neither treatment reverses advanced, bone-on-bone hip arthritis. Both are best suited to mild-to-moderate arthritis, where the goal is delaying or avoiding surgery, not replacing a joint that has already worn down completely.
The Same Question We Get About Knees, Now About Hips
We’ve written before about PRP versus cortisone for the knee, since that’s the joint that generates the most volume of this exact question. Hip arthritis follows a similar decision tree, but the hip is a deeper, less accessible joint than the knee, and the direct research comparing PRP to cortisone specifically in the hip is thinner than the knee literature. This article extends what the knee research shows, is explicit about where hip-specific evidence exists, and flags the parts that are reasonable extrapolation rather than direct proof.
Why Cortisone Feels Like the Obvious First Move
Cortisone (corticosteroid) injections have been the default first-line injection for hip arthritis for decades, and it’s not hard to understand why. Most patients feel meaningfully better within days, the injection itself takes minutes, and it doesn’t require any lab processing or specialized preparation.
The problem is what cortisone doesn’t do. It reduces inflammation and blunts pain signaling in the joint, but it doesn’t repair damaged cartilage. Hip-specific research has raised genuine concern here. A 2024 study published in the Journal of Orthopaedic Surgery and Research found that intra-articular hip corticosteroid injections offered no meaningful benefit in delaying time to total hip arthroplasty (DOI: 10.1186/s13018-024-05115-x). A 2025 systematic review went further, documenting cases of rapidly progressive osteoarthritis, osteonecrosis, and femoral head collapse following intra-articular hip corticosteroid injections, particularly in patients with mild or minimal arthritis on imaging relative to their pain (ScienceDirect, S2666061X25000951). This does not mean cortisone is dangerous for every hip patient, but it does mean repeated use, particularly in a joint that isn’t severely arthritic yet, carries real downside that deserves an honest conversation.
Where PRP Fits Into the Hip Conversation
PRP takes a fundamentally different approach. Rather than suppressing the inflammatory response, it delivers a concentrated dose of your own platelets and their growth factors directly into the joint, aimed at supporting the tissue’s own repair signaling rather than just quieting symptoms.
Here is where we want to be precise about the evidence rather than overstate it. A 2021 systematic review and meta-analysis of Level I and II randomized controlled trials (211 PRP patients, 197 HA patients, published in PubMed 34785294) found that PRP and hyaluronic acid produce similarly beneficial outcomes for hip osteoarthritis overall. PRP showed a significant edge over HA at two months, but that advantage did not hold at six and twelve months, where the two treatments performed comparably on WOMAC, VAS, and Harris Hip Score measures. That is a different pattern than what shows up in the knee literature, where PRP tends to separate favorably from cortisone specifically at six and twelve months. We have not found a published trial comparing PRP directly to cortisone in the hip, so the strongest evidence-based case for PRP at the hip right now is its safety profile relative to cortisone’s structural risks, not a proven long-term efficacy edge the way there is at the knee.
The Part That’s Actually Different About the Hip
The hip joint sits deep beneath a significant layer of muscle and soft tissue, unlike the knee, which is comparatively superficial and easier to access by feel alone. This makes precise, ultrasound-guided injection placement considerably more important for the hip than it is for many other joints. An imprecisely placed hip injection, whether cortisone or PRP, may miss the joint space entirely, which is part of why we perform all hip injections under direct ultrasound guidance rather than by external landmarks alone.
Setting Expectations for Both
Neither cortisone nor PRP will reverse advanced, bone-on-bone hip arthritis. Both are best suited to mild-to-moderate arthritis, where the clinical goal is reducing pain, improving function, and delaying or potentially avoiding a hip replacement, not undoing damage that has already progressed to end-stage.
Cortisone’s relief tends to be faster but shorter-lived, and repeat use carries the structural concerns described above. PRP’s relief builds more gradually, generally over several weeks, and current hip-specific evidence puts it roughly on par with HA for efficacy, with a materially better safety profile than repeated cortisone.
Frequently Asked Questions
How long does PRP relief last for hip arthritis compared to cortisone?
Individual results vary, but cortisone’s relief is generally faster and shorter-lived. PRP tends to build more gradually over several weeks and, in the hip-specific research available, performs comparably to hyaluronic acid at six and twelve months rather than clearly outlasting it. The clearer advantage for PRP at the hip right now is avoiding cortisone’s structural risk, not a proven durability edge.
Can I get a cortisone shot now and try PRP later?
This is a common sequence, though your physician may recommend spacing between the two, since cortisone can potentially blunt the biological response PRP is trying to stimulate if given too close together.
Is PRP for the hip covered by insurance?
Coverage varies by plan, and PRP is frequently classified as investigational by insurers. Our team can review your specific situation during a consultation. See our full PRP insurance coverage guide for more detail.
How many cortisone shots is too many for a hip?
There’s no universal number, but the hip-specific research on rapidly progressive osteoarthritis and osteonecrosis risk with repeated use is exactly why we recommend discussing alternatives like PRP if you’ve already had more than one or two injections without lasting relief.
Making a More Informed Choice for Your Hip
If you’ve been offered another cortisone shot for your hip and are wondering whether that’s actually the best next step, we can walk you through your specific imaging and give you an honest answer. If you’d rather explore whether you can avoid surgery altogether, our guide on hip arthritis surgery alternatives covers that broader decision. We see patients at eight locations across DC, Maryland, and Virginia.


